Benlysta (belimumab)

pCPA File Number: 21220

Negotiation Status:

Active Negotiation

Indication(s):

Systemic lupus erythematosus

Sponsor/Manufacturer:

GlaxoSmithKline Inc.

CADTH Project Number:

SR0616

pCPA Engagement Letter Issued:

2023-01-25

Negotiation Process Concluded:

Not Applicable